Author

Jiarui Ma

Observed name: Ma, Jiarui

Institutions: Yan'an University, Ningxia Hui Autonomous Region Peoples Hospital, Ningxia Medical University

Observed institutions: Nanjing University of Chinese Medicine, Shanghai Medical College of Fudan University, Fudan University, Yan'an University, Ningxia Hui Autonomous Region Peoples Hospital, Ningxia Medical University

ORCID: 0000-0002-1152-1050

Observed ORCID: 0000-0002-1152-1050

OpenAlex ID: A5103274861

Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review

2021 · Shuangqiu Wang, Jiarui Ma, et al. · Drug Design Development and Therapy · 90

Intervention and research progress of gut microbiota-immune-nervous system in autism spectrum disorders among students

2025 · Min Zhou, Baoming Niu, et al. · Frontiers in Microbiology · 26

Prognostic significance of serum interleukin-6 in severe/critical COVID-19 patients treated with tocilizumab: a detailed observational study analysis

2024 · Panpan Liang, Yan Li, et al. · Scientific Reports · 9

Investigation of the Potential Mechanism Governing the Effect of the Shen Zhu San on COVID‐19 by Network Pharmacology

2020 · Yuxuan Wang, Yuhua Ru, et al. · Evidence-based Complementary and Alternative Medicine · 8

The clinical and pathological histology efficacy of biological therapy for severe asthma with a phenotype of type 2 inflammation - systematic review

2025 · Junhui Ma, Qiang Ma, et al. · Frontiers in Immunology · 6

Poor statistical power in population-based association study of gene interaction

2024 · Jiarui Ma, Jian Li, et al. · BMC Medical Genomics · 3

Works count: 8

Citation count: 142

H-index: 5

I10-index: 2